Till startsida
To content Read more about how we use cookies on gu.se

Key publications

Pingitore P, Dongiovanni P, Motta BM, Meroni M, Lepore SM, Mancina RM, Pelusi S, Russo C, Caddeo A, Rossi G, Montalcini T, Pujia A, Wiklund O, Valenti L*, Romeo S*.
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis.
Hum Mol Genet doi: 10.1093/hmg/ddw341 (2016). * corresponding authors

Pingitore P, Lepore SM, Pirazzi C, Mancina RM, Motta BM, Valenti L, Berge KE, Retterstøl K, Leren TP, Wiklund O, Romeo S.
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
J Clin Lipidol 10(4):816-23. doi: 10.1016/j.jacl.2016.02.015. (2016)

Mancina RM, Dongiovanni P, Petta S, Pingitore P, Meroni M, Rametta R, Borén J, Montalcini T, Pujia A, Wiklund O, Hindy G, Spagnuolo R, Motta BM, Pipitone RM, Craxì A, Fargion S, Nobili V, Käkelä P, Kärjä V, Männistö V, Pihlajamäki J, Reilly DF, Castro-Perez J, Kozlitina J*, Valenti L*, Romeo S*.
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Gastroenterology 150(5):1219-1230.e6. doi: 10.1053/j.gastro.2016.01.032. (2016) * corresponding authors

Dongiovanni P, Petta S, Mannisto V, Mancina RM, Pipitone R, Karja V, Maggioni M, Kakela P, Wiklund O, Mozzi E, Grimaudo S, Kaminska D, Rametta R, Craxi A, Fargion S, Nobili V, Romeo S*, Pihlajamaki J*, Valenti L*.
Statin use and non-alcoholic steatohepatitis in at risk individuals.
J Hepatol 63(3):705-12. doi: 10.1016/j.jhep.2015.05.006. (2015) * corresponding authors

Dongiovanni P, Petta S, Maglio C, Fracanzani AL, Pipitone R, Mozzi E, Motta BM, Kaminska D, Rametta R, Grimaudo S, Pelusi S, Montalcini T, Alisi A, Maggioni M, Kärjä V, Borén J, Käkelä P, Di Marco V, Xing C, Nobili V, Dallapiccola B, Craxi A, Pihlajamäki J, Fargion S, Sjöström L, Carlsson LM, Romeo S*, Valenti L*.
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.
Hepatology 61(2):506-14. (2015) * corresponding authors

Maglio C, Mancina RM, Motta BM, Stef M, Pirazzi C, Palacios L, Askaryar N, Borén J, Wiklund O, Romeo S.
Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing.
J Intern Med doi: 10.1111/joim.12263 (2014)

Pirazzi C, Valenti L, Motta BM, Pingitore P, Hedfalk K, Mancina RM, Burza MA, Indiveri C, Ferro Y, Montalcini T, Maglio C, Dongiovanni P, Fargion S, Rametta R, Pujia A, Andersson L, Ghosal S, Levin M, Wiklund O, Iacovino M, Borén J, Romeo S.
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.
Hum Mol Genet 23:4077-85 (2014)

Pingitore P, Pirazzi C, Mancina RM, Motta BM, Indiveri C, Pujia A, Montalcini T, Hedfalk K, Romeo S. 
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function.
Biochim Biophys Acta 1841:574-80 (2014)

Pirazzi C, Adiels M, Burza MA, Mancina RM, Levin M, Ståhlman M, Taskinen MR, Orho-Melander M, Perman J, Pujia A, Andersson L, Maglio C, Montalcini T, Wiklund O, Borén J, Romeo S.
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
J Hepatol 57:1276-82 (2012)

Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, Pila S, Huang-Doran I, Cossu E, Loche S, Baroni MG.
The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
J Hepatol 53:335-8 (2010)

Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, Cohen JC.
Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.
J Clin Invest 119:70-9 (2009)

Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH.
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Nat Genet 40:1461-5 (2008)

Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC.
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
Nat Genet 39:513-6 (2007)

View complete list of publications


Sterfano Romeo

Contact Information

Stefano Romeo

The Wallenberg Laboratory, Sahlgrenska University Hospital, SE-413 45 Göteborg

Visiting Address:
Bruna Stråket 16

+46 (0)31-342 6735

Complete list of publications

View list of publications on PubMed.

Page Manager: Anna Hallén|Last update: 1/13/2017

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?